SquamousCellCarcinomaofSkin near Teaneck, NJ

Biography: Dr. Ryan Moy is an Assistant Professor of Medicine and medical oncologist at Columbia University Irving Medical Center where he specializes in the treatment of gastrointestinal malignancies, with a focus on esophageal and stomach cancers. He received his MD/PhD from the University of Pennsylvania and completed internship and residency training in Internal Medicine at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He then completed fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer Center and postdoctoral research at The Rockefeller University. Dr. Moy is actively involved in translational research to understand the biological mechanisms that regulate metastasis, the primary driver of mortality in gastrointestinal cancers. He has performed laboratory-based research to define critical genes that promote liver metastasis in colorectal cancer. He is also conducting research to discover key vulnerabilities in esophageal and gastric cancers, with the goal of translating these findings from the lab to develop more effective treatments for patients. As an active member of the gastrointestinal oncology and experimental therapeutics groups, Dr. Moy is involved in developing and leading clinical trials investigating novel targeted and immunotherapy treatments for esophagogastric cancer and other malignancies. His work has been recognized by several awards including a Damon Runyon Cancer Research Foundation Fellow Award and a National Cancer Institute (NCI) K08 Career Development Award. Dr. Moy works as part of a multidisciplinary team with the mission of delivering compassionate and state-of-the-art oncologic care to each patient, using a precision medicine approach to provide innovative and promising treatments.

Biography: Dr. Juan-Manuel Schvartzman, MD is an Oncology Specialist who practices in New York, NY. He is 46 years old and has been practicing for 23 years. Dr. Juan-Manuel Schvartzman, MD is affiliated with Newyork-Presbyterian.

Biography: Dr. Yoanna Pumpalova is an Assistant Professor of Medicine and medical oncologist at Columbia University Irving Medical Center where she specializes in the treatment of gastrointestinal malignancies, with a focus on colorectal and anal cancers. She received her MD from Weill Cornell Medical College and completed internship and residency training in Internal Medicine and Global Health at Stanford University. She then completed fellowship training in Medical Oncology at Columbia University/New York Presbyterian Hospital. Dr. Pumpalova works as part of a multidisciplinary team with the mission of delivering compassionate and state-of-the-art oncologic care to each patient, using a precision medicine approach to provide innovative and promising treatments. Dr. Pumpalova is actively involved in translational research to understand the biological mechanisms driving early onset colorectal cancer. She collaborates with Dr. Joel Gabre, a gastroenterologist and clinician scientist and Dr. Beatrice Dionigi, colorectal surgeon, on research to understand how early onset colorectal cancer differs from average onset colorectal cancer, with the goal of uncovering novel ways to treat all patients with colorectal cancer. Dr. Pumpalova is also the site principal investigator of industry-sponsored clinical trials investigating novel therapies for the treatment of colorectal cancer. Further, Dr. Pumpalova conducts studies in low- and middle-income countries focused on early detection and screening for colorectal cancer. She has active studies in South Africa and Dominican Republic. Her research goal is to improve outcomes for patients diagnosed with colorectal cancer, regardless of where they reside. Her work has been recognized by several awards including an ASCO Young Investigator Award and ASCO Career Development Award. In the NewsColumbia Researchers Seek Answers for Rise of Colon Cancer in Younger PatientsWhat to Know About the Rise of Colorectal Cancer in Younger PeopleExploring Strategies for Earlier Colon Cancer Detection in Sub-Saharan Africa